Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.

Several successful pathogens have evolved mechanisms to evade host defense, resulting in the establishment of persistent and chronic infections. One such pathogen, Porphyromonas gingivalis, induces chronic low-grade inflammation associated with local inflammatory bone loss and systemic inflammation...

Full description

Bibliographic Details
Main Authors: Connie Slocum, Stephen R Coats, Ning Hua, Carolyn Kramer, George Papadopoulos, Ellen O Weinberg, Cynthia V Gudino, James A Hamilton, Richard P Darveau, Caroline A Genco
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-07-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC4092147?pdf=render
id doaj-cac4e6ca31474606be3a0c5795c2b396
record_format Article
spelling doaj-cac4e6ca31474606be3a0c5795c2b3962020-11-25T00:58:00ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742014-07-01107e100421510.1371/journal.ppat.1004215Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.Connie SlocumStephen R CoatsNing HuaCarolyn KramerGeorge PapadopoulosEllen O WeinbergCynthia V GudinoJames A HamiltonRichard P DarveauCaroline A GencoSeveral successful pathogens have evolved mechanisms to evade host defense, resulting in the establishment of persistent and chronic infections. One such pathogen, Porphyromonas gingivalis, induces chronic low-grade inflammation associated with local inflammatory bone loss and systemic inflammation manifested as atherosclerosis. P. gingivalis expresses an atypical lipopolysaccharide (LPS) structure containing heterogeneous lipid A species, that exhibit Toll-like receptor-4 (TLR4) agonist or antagonist activity, or are non-activating at TLR4. In this study, we utilized a series of P. gingivalis lipid A mutants to demonstrate that antagonistic lipid A structures enable the pathogen to evade TLR4-mediated bactericidal activity in macrophages resulting in systemic inflammation. Production of antagonistic lipid A was associated with the induction of low levels of TLR4-dependent proinflammatory mediators, failed activation of the inflammasome and increased bacterial survival in macrophages. Oral infection of ApoE(-/-) mice with the P. gingivalis strain expressing antagonistic lipid A resulted in vascular inflammation, macrophage accumulation and atherosclerosis progression. In contrast, a P. gingivalis strain producing exclusively agonistic lipid A augmented levels of proinflammatory mediators and activated the inflammasome in a caspase-11-dependent manner, resulting in host cell lysis and decreased bacterial survival. ApoE(-/-) mice infected with this strain exhibited diminished vascular inflammation, macrophage accumulation, and atherosclerosis progression. Notably, the ability of P. gingivalis to induce local inflammatory bone loss was independent of lipid A expression, indicative of distinct mechanisms for induction of local versus systemic inflammation by this pathogen. Collectively, our results point to a pivotal role for activation of the non-canonical inflammasome in P. gingivalis infection and demonstrate that P. gingivalis evades immune detection at TLR4 facilitating chronic inflammation in the vasculature. These studies support the emerging concept that pathogen-mediated chronic inflammatory disorders result from specific pathogen-mediated evasion strategies resulting in low-grade chronic inflammation.http://europepmc.org/articles/PMC4092147?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Connie Slocum
Stephen R Coats
Ning Hua
Carolyn Kramer
George Papadopoulos
Ellen O Weinberg
Cynthia V Gudino
James A Hamilton
Richard P Darveau
Caroline A Genco
spellingShingle Connie Slocum
Stephen R Coats
Ning Hua
Carolyn Kramer
George Papadopoulos
Ellen O Weinberg
Cynthia V Gudino
James A Hamilton
Richard P Darveau
Caroline A Genco
Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
PLoS Pathogens
author_facet Connie Slocum
Stephen R Coats
Ning Hua
Carolyn Kramer
George Papadopoulos
Ellen O Weinberg
Cynthia V Gudino
James A Hamilton
Richard P Darveau
Caroline A Genco
author_sort Connie Slocum
title Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
title_short Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
title_full Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
title_fullStr Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
title_full_unstemmed Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
title_sort distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
publisher Public Library of Science (PLoS)
series PLoS Pathogens
issn 1553-7366
1553-7374
publishDate 2014-07-01
description Several successful pathogens have evolved mechanisms to evade host defense, resulting in the establishment of persistent and chronic infections. One such pathogen, Porphyromonas gingivalis, induces chronic low-grade inflammation associated with local inflammatory bone loss and systemic inflammation manifested as atherosclerosis. P. gingivalis expresses an atypical lipopolysaccharide (LPS) structure containing heterogeneous lipid A species, that exhibit Toll-like receptor-4 (TLR4) agonist or antagonist activity, or are non-activating at TLR4. In this study, we utilized a series of P. gingivalis lipid A mutants to demonstrate that antagonistic lipid A structures enable the pathogen to evade TLR4-mediated bactericidal activity in macrophages resulting in systemic inflammation. Production of antagonistic lipid A was associated with the induction of low levels of TLR4-dependent proinflammatory mediators, failed activation of the inflammasome and increased bacterial survival in macrophages. Oral infection of ApoE(-/-) mice with the P. gingivalis strain expressing antagonistic lipid A resulted in vascular inflammation, macrophage accumulation and atherosclerosis progression. In contrast, a P. gingivalis strain producing exclusively agonistic lipid A augmented levels of proinflammatory mediators and activated the inflammasome in a caspase-11-dependent manner, resulting in host cell lysis and decreased bacterial survival. ApoE(-/-) mice infected with this strain exhibited diminished vascular inflammation, macrophage accumulation, and atherosclerosis progression. Notably, the ability of P. gingivalis to induce local inflammatory bone loss was independent of lipid A expression, indicative of distinct mechanisms for induction of local versus systemic inflammation by this pathogen. Collectively, our results point to a pivotal role for activation of the non-canonical inflammasome in P. gingivalis infection and demonstrate that P. gingivalis evades immune detection at TLR4 facilitating chronic inflammation in the vasculature. These studies support the emerging concept that pathogen-mediated chronic inflammatory disorders result from specific pathogen-mediated evasion strategies resulting in low-grade chronic inflammation.
url http://europepmc.org/articles/PMC4092147?pdf=render
work_keys_str_mv AT connieslocum distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
AT stephenrcoats distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
AT ninghua distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
AT carolynkramer distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
AT georgepapadopoulos distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
AT ellenoweinberg distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
AT cynthiavgudino distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
AT jamesahamilton distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
AT richardpdarveau distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
AT carolineagenco distinctlipidamoietiescontributetopathogeninducedsitespecificvascularinflammation
_version_ 1725221712046325760